Cross-institution positioning
Feb 5, 2026Strong institutional accumulation. 1 accumulating across 1 comparable institution.
Source: Schedule 13 researchCAMP Institutional Ownership
Camp4 Therapeutics Corp
Latest stored close $3.70 as of Oct 8, 2026 View live quote ↗
STOCKNODE Outlook
Buy
72/100
1 tracked · 1 comparable
Latest filing
Feb 5, 2026
Positive breadth
1 positive · 0 negative
Recent close
$3.70
Research confidence
Limited
Institutional Research 83/100 · 1 accumulating · 0 reducing / exited
Ownership history
Reported ownership % history
Latest filing Feb 5, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating1
Newly reported0
Reducing / exited
0
52-week position
—
Institutional Intelligence
Why STOCKNODE says Buy
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Buy 72/100
Confidence:Limited
Why this signal
- 1 tracked institution accumulating versus 0 reducing/exited.
- 1 tracked institution shows persistent accumulation.
- 1 tracked institution show accelerating accumulation.
- Latest comparable Form 13F activity is net positive across tracked managers.
- Recent insider purchase activity confirms the institutional direction.
Institutional
82/100
Insiders
63/100
Fundamentals
51/100
Events
50/100
Quarterly 13F activity
Jun 30, 20262 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Aug 31, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 5 purchases by 4 reporting owners and 6 sales by 2 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Material company events
Sep 28, 20266 non-amendment material events in the last 90 days; 3 capital-related filing/events (1 equity-related, 0 debt-related); Latest classified evidence: Regulation FD disclosure. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataSEC fundamentals
Aug 13, 2026Revenue +18.8% YoY; Net income -166.4% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 36% through its reported 52-week range; +58.1% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Schedule 13G amendment from Fidelity / FMR.
Filed Feb 5, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Feb 5, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Fidelity / FMR
Filed Feb 5, 2026
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Fidelity / FMR
Filed Feb 5, 2026
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases11 reporting owner(s)
30-day sales62 reporting owner(s)
90-day purchase breadth4Multi-insider
90-day sale breadth2Multi-insider
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Gold Kelly | POpen-market or private purchase | Common Stock | 10.0K | $3.96 | Indirect | Sep 2, 2026 |
| Aug 27, 2026 | Schwab Andrew J. | SOpen-market or private sale | Common Stock | 400.0K | $4.04 | Indirect | Aug 31, 2026 |
| Aug 24, 2026 | Schwab Andrew J. | SOpen-market or private sale | Common Stock | 10 | $4.50 | Indirect | Aug 26, 2026 |
| Aug 21, 2026 | Schwab Andrew J. | SOpen-market or private sale | Common Stock | 32.0K | $4.50 | Indirect | Aug 21, 2026 |
| Aug 20, 2026 | Schwab Andrew J. | SOpen-market or private sale | Common Stock | 114.7K | $4.54 | Indirect | Aug 21, 2026 |
| Aug 19, 2026 | Schwab Andrew J. | SOpen-market or private sale | Common Stock | 45.1K | $4.76 | Indirect | Aug 21, 2026 |
| Aug 19, 2026 | Tardiff Daniel | SOpen-market or private sale | Common Stock | 1.7K | $4.76 | Direct | Aug 19, 2026 |
| Aug 3, 2026 | Mandel-Brehm Josh | POpen-market or private purchase | Common Stock | 6.6K | $1.65 | Direct | Aug 5, 2026 |
| Aug 3, 2026 | Gold Kelly | POpen-market or private purchase | Common Stock | 6.6K | $1.65 | Direct | Aug 5, 2026 |
| Aug 3, 2026 | Maricich Yuri | POpen-market or private purchase | Common Stock | 6.6K | $1.65 | Direct | Aug 5, 2026 |
| Aug 3, 2026 | Young Richard A | POpen-market or private purchase | Common Stock | 16.4K | $1.65 | Direct | Aug 5, 2026 |
| Aug 3, 2026 | Schwab Andrew J. | AGrant, award, or other acquisition · derivative | Pre-Funded Warrant (Right to Buy) | 3.2M | $1.53 | Indirect | Aug 5, 2026 |
| Aug 3, 2026 | 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P., 5AM Partners VII, LLC, 5AM Ventures VII, L.P., PARMAR KUSH | POpen-market or private purchase · derivative | Pre-Funded Warrant (Right to Buy) | 3.2M | $1.53 | Indirect | Aug 5, 2026 |
| Apr 1, 2026 | MacLean Michael F | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 56.0K | $0.00 | Direct | Apr 3, 2026 |
| Apr 1, 2026 | Tardiff Daniel | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 170.0K | $0.00 | Direct | Apr 3, 2026 |
| Apr 1, 2026 | Maricich Yuri | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 215.0K | $0.00 | Direct | Apr 3, 2026 |
| Apr 1, 2026 | Gold Kelly | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 215.0K | $0.00 | Direct | Apr 3, 2026 |
| Apr 1, 2026 | Mandel-Brehm Josh | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 580.0K | $0.00 | Direct | Apr 3, 2026 |
SEC company-event context
Material company events
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
30-day material events1
90-day capital-related3
90-day equity-related1
90-day debt-related0
View recent company-event filing evidence
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 28, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Aug 13, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Aug 12, 2026 | 424B3 | — | Prospectus filing | Capital-related | Filing |
| Aug 6, 2026 | S-3 | — | Shelf securities registration | Capital-related | Filing |
| Aug 4, 2026 | 8-K | 1.01, 3.02, 7.01, 9.01 | Material definitive agreement; Unregistered sale of equity securities; Regulation FD disclosure; Financial statements / exhibits | Equity | Filing |
| Jul 27, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Jun 12, 2026 | 8-K | 5.02, 5.07, 9.01 | Director or executive change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| May 14, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 7, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Revenue
$1.8M
Q2 2026
+18.8% YoY 10-Q filed Aug 13, 2026
Operating income
$-13.4M
Q2 2026
-2.7% YoY 10-Q filed Aug 13, 2026
Operating margin
-752.1%
Q2 2026
+118.2 pts YoY 10-Q filed Aug 13, 2026
Net income
$-33.5M
Q2 2026
-166.4% YoY 10-Q filed Aug 13, 2026
Diluted EPS
$-0.58
Q2 2026
+6.5% YoY 10-Q filed Aug 13, 2026
Operating cash flow
$-23.7M
YTD through Jun 30, 2026
+3.9% YoY 10-Q filed Aug 13, 2026
Free cash flow
$-23.8M
YTD through Jun 30, 2026
+4.5% YoY 10-Q filed Aug 13, 2026
Cash & equivalents
$86.4M
As of Jun 30, 2026
10-Q filed Aug 13, 2026
Assets
$93.4M
As of Jun 30, 2026
10-Q filed Aug 13, 2026
Liabilities
$94.1M
As of Jun 30, 2026
10-Q filed Aug 13, 2026
Stockholders’ equity
$-693.0K
As of Jun 30, 2026
-101.7% YoY 10-Q filed Aug 13, 2026
Shares outstanding
62.8M
As of Aug 12, 2026
10-Q filed Aug 13, 2026
View recent revenue trend
Quarterly
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $1.8M | +18.8% |
| Ended Jun 30, 2025 | $1.5M | — |
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$4.19
View live quote ↗
52-week low
$2.20
Sep 19, 2025
52-week high
$7.75
Mar 9, 2026
Below 52-week high
45.9%
1W return
-4.8%
1M return
-23.0%
3M return
+5.8%
6M return
-22.6%
YTD return
-31.6%
1Y return
+58.1%
30-day volatility
98.8%
90-day volatility
89.6%
1Y max drawdown
-57.8%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 4 filing(s) · 1 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Dec 31, 2025 observed Feb 5, 2026 filed · 36d Schedule 13G amendment | Reported accumulation | 4.9M +1.8M | 9.50% +2.80 pts | $6.13 | $3.59 | $3.70 |
| Fidelity / FMR CIK0000315066 | Oct 31, 2025 observed Nov 7, 2025 filed · 7d Schedule 13G amendment | Reported accumulation | 3.1M +122.2K | 6.70% -8.30 pts | $4.16 | $4.25 | $3.70 |
| Fidelity / FMR CIK0000315066 | Sep 30, 2025 observed Oct 7, 2025 filed · 7d Initial Schedule 13G | Initial Schedule 13G | 3.0M | 15.00% | $3.00 | $3.29 | $3.70 |
Explore more institutional activity
Related research
Compare CAMP with other securities showing similar institutional activity or recent accumulation across several tracked institutions.